These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 67089)

  • 21. Formation and composition of the C3 activating enzyme complex of the properdin system. Sequential assembly of its components on solid-phase trypsin-agarose.
    Vogt W; Schmidt G; Dieminger L; Lynen R
    Z Immunitatsforsch Exp Klin Immunol; 1975 Jul; 149(5):440-55. PubMed ID: 126576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus.
    Kostavasili I; Sahu A; Friedman HM; Eisenberg RJ; Cohen GH; Lambris JD
    J Immunol; 1997 Feb; 158(4):1763-71. PubMed ID: 9029114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alternative pathway complement activation in rheumatoid arthritis.
    El-Ghobarey A; Whaley K
    J Rheumatol; 1980; 7(4):453-60. PubMed ID: 6158571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Babesia rodhaini: requirement of complement for penetration of human erythrocytes.
    Chapman WE; Ward PA
    Science; 1977 Apr; 196(4285):67-70. PubMed ID: 841340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the mechanism of bacterial resistance to complement-mediated killing. I. Terminal complement components are deposited and released from Salmonella minnesota S218 without causing bacterial death.
    Joiner KA; Hammer CH; Brown EJ; Cole RJ; Frank MM
    J Exp Med; 1982 Mar; 155(3):797-808. PubMed ID: 6801179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of the alternative complement pathway with rabbit erythrocytes by circumvention of the regulatory action of endogenous control proteins.
    Fearon DT; Austen KF
    J Exp Med; 1977 Jul; 146(1):22-33. PubMed ID: 559720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Properdin: initiation of alternative complement pathway.
    Fearon DT; Austen KF
    Proc Natl Acad Sci U S A; 1975 Aug; 72(8):3220-4. PubMed ID: 1059108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of factor B and C3 in guinea pig serum by zymosan or by activated properdin depends on the presence of factor D.
    Brade V; Bentley C; Kossorotow A; Bitter-Suermann D
    Monogr Allergy; 1977; 12():83-5. PubMed ID: 917024
    [No Abstract]   [Full Text] [Related]  

  • 29. Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase.
    Fearon DT; Austen KF
    J Exp Med; 1975 Oct; 142(4):856-63. PubMed ID: 1185108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of activated properdin with complexes of properdin with C3.
    Whiteman LY; Purkall DB; Ruddy S
    J Immunol; 1991 Aug; 147(4):1344-51. PubMed ID: 1869827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of the alternative pathway of complement in childhood acute lymphoblastic leukemia.
    Kalwinsky DK; Urmson JR; Stitzel AE; Spitzer RE
    J Lab Clin Med; 1976 Nov; 88(5):745-56. PubMed ID: 1068203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rosétte formation between human b lymphocytes and zymosan-C3 complexes using different complement sources.
    Kajdacsy-Balla AA; Mendes NF
    J Immunol Methods; 1976; 9(3-4):205-9. PubMed ID: 1082460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Substrate modulation as a control mechanism in the activation of plasma multienzyme systems.
    Vogt W
    Adv Exp Med Biol; 1979; 120B():125-31. PubMed ID: 517230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of the complement intermediate C56 to zymosan in acute phase human sera.
    Baker PJ; Rubin LG; Lint TF; McLeod BC; Gewurz H
    Clin Exp Immunol; 1975 Apr; 20(1):113-24. PubMed ID: 1106918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemolysis of normal human erythrocytes by autologous serum complement.
    Kitamura H; Nagano A; Kitano E
    Int Arch Allergy Immunol; 1993; 100(3):209-14. PubMed ID: 8453307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.
    Fearon DT; Daha MR; Strom TB; Weiler JM; Carpenter CB; Austen KF
    Transplant Proc; 1977 Mar; 9(1):729-39. PubMed ID: 325806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assembly of the membrane attack complex promotes decay of the alternative pathway C3 convertase on Neisseria gonorrhoeae.
    Densen P; McRill CM; Ross SC
    J Immunol; 1988 Dec; 141(11):3902-9. PubMed ID: 3141507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolism of the fifth component of complement, and its relation to metabolism of the third component, in patients with complement activation.
    Sissons JG; Liebowitch J; Amos N; Peters DK
    J Clin Invest; 1977 Apr; 59(4):704-15. PubMed ID: 845257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of granulocyte neutral proteases on complement components.
    Johnson U; Ohlsson K; Olsson I
    Scand J Immunol; 1976; 5(4):421-6. PubMed ID: 181839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of C3b as the major serum protein that stimulates prostaglandin and thromboxane synthesis by macrophages.
    Hsueh W; Arroyave CM; Jordan RL
    Prostaglandins; 1984 Dec; 28(6):889-904. PubMed ID: 6240667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.